136 related articles for article (PubMed ID: 9226155)
21. Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog.
Zhang Y; Dawson MI; Mohammad R; Rishi AK; Farhana L; Feng KC; Leid M; Peterson V; Zhang XK; Edelstein M; Eilander D; Biggar S; Wall N; Reichert U; Fontana JA
Blood; 2002 Oct; 100(8):2917-25. PubMed ID: 12351403
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide.
Zhang Y; Shen WL
Cell Biol Int; 2003; 27(12):953-8. PubMed ID: 14642526
[TBL] [Abstract][Full Text] [Related]
23. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
[TBL] [Abstract][Full Text] [Related]
24. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells.
Florea AM; Büsselberg D
Toxicol Lett; 2008 Jun; 179(1):34-42. PubMed ID: 18485628
[TBL] [Abstract][Full Text] [Related]
26. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
Rojewski MT; Baldus C; Knauf W; Thiel E; Schrezenmeier H
Br J Haematol; 2002 Mar; 116(3):555-63. PubMed ID: 11849211
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
[TBL] [Abstract][Full Text] [Related]
28. As2O3 induces apoptosis of the human B lymphoma cell line MBC-1.
Shen L; Chen TX; Wang YP; Lin Z; Zhao HJ; Zu YZ; Wu G; Ying DM
J Biol Regul Homeost Agents; 2000; 14(2):116-9. PubMed ID: 10841286
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676
[TBL] [Abstract][Full Text] [Related]
31. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells.
Bairey O; Vanichkin A; Shpilberg O
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e77-85. PubMed ID: 19208092
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
33. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
[TBL] [Abstract][Full Text] [Related]
34. Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.
Wang SS; Zhang T; Wang XL; Hong L; Qi QH
World J Gastroenterol; 2003 May; 9(5):930-5. PubMed ID: 12717832
[TBL] [Abstract][Full Text] [Related]
35. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression.
Zheng J; Deng YP; Lin C; Fu M; Xiao PG; Wu M
Int J Cancer; 1999 Jul; 82(2):286-92. PubMed ID: 10389765
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
Chen Z; Chen GQ; Shen ZX; Chen SJ; Wang ZY
Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
[TBL] [Abstract][Full Text] [Related]
38. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide.
Zhang TC; Cao EH; Li JF; Ma W; Qin JF
Eur J Cancer; 1999 Aug; 35(8):1258-63. PubMed ID: 10615238
[TBL] [Abstract][Full Text] [Related]
39. Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.
Soignet SL; Tong WP; Hirschfeld S; Warrell RP
Cancer Chemother Pharmacol; 1999; 44(5):417-21. PubMed ID: 10501916
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
Huan SY; Yang CH; Chen YC
Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
